1-12 of 12
Lena Specht
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Stage I-II nodular lymphocyte-predominant Hodgkin lymphoma: a multi-institutional study of adult patients by ILROG

Clinical Trials & Observations
Michael S. Binkley, M. Shahzad Rauf, Sarah A. Milgrom, Chelsea C. Pinnix, Richard Tsang, Michael Dickinson, Andrea K. Ng, Kenneth B. Roberts, Sarah Gao, Alex Balogh, Umberto Ricardi, Mario Levis, Carla Casulo, Michael Stolten, Lena Specht, John P. Plastaras, Christopher Wright, Christopher R. Kelsey, Jessica L. Brady, N. George Mikhaeel, Bradford S. Hoppe, Stephanie A. Terezakis, Marco Picardi, Roberta Della Pepa, Youlia Kirova, Saad Akhtar, Irfan Maghfoor, Julie L. Koenig, Christopher Jackson, Erin Song, Shuchi Sehgal, Ranjana H. Advani, Yasodha Natkunam, Louis S. Constine, Hans T. Eich, Andrew Wirth, Richard T. Hoppe
Journal: Blood
Blood (2020) 135 (26): 2365–2374.
https://doi.org/10.1182/blood.2019003877
Published: 2020
Includes: Supplemental data
Journal Articles

ILROG emergency guidelines for radiation therapy of hematological malignancies during the COVID-19 pandemic

Joachim Yahalom, Bouthaina Shbib Dabaja, Umberto Ricardi, Andrea Ng, N. George Mikhaeel, Ivan R. Vogelius, Tim Illidge, Shunan Qi, Andrew Wirth, Lena Specht
Journal: Blood
Blood (2020) 135 (21): 1829–1832.
https://doi.org/10.1182/blood.2020006028
Published: 2020
Includes: Supplemental data
Journal Articles

Proton therapy for adults with mediastinal lymphomas: the International Lymphoma Radiation Oncology Group guidelines

Clinical Trials & Observations
Bouthaina Shbib Dabaja, Bradford S. Hoppe, John P. Plastaras, Wayne Newhauser, Katerina Rosolova, Stella Flampouri, Radhe Mohan, N. George Mikhaeel, Youlia Kirova, Lena Specht, Joachim Yahalom
Journal: Blood
Blood (2018) 132 (16): 1635–1646.
https://doi.org/10.1182/blood-2018-03-837633
Published: 2018
Includes: Supplemental data
Journal Articles

PET-Based Response after 2 Cycles of Brentuximab Vedotin in Combination with AVD for First-Line Treatment of Unfavorable Early-Stage Hodgkin Lymphoma: First Analysis of the Primary Endpoint of Breach, a Randomized Phase II Trial of Lysa-FIL-EORTC Intergroup

Luc-Matthieu Fornecker, Julien Lazarovici, MD, Igor Aurer, PhD, Rene-Olivier Casasnovas, MD, Anne-Claire Gac, Christophe Bonnet, MD PhD, Krimo Bouabdallah, MD, Aurore Perrot, MD, Lena Specht, Mohamed Touati, Jean Claude Eisenmann, Cecile Borel, MD, Aspasia Stamatoullas, MD, Emmanuelle Nicolas-Virelizier, MD, Laurent Pascal, Pieternella Lugtenburg, Monica Bellei, MSc, PhD, Alexandra traverse-Glehen, MD PhD, Christiane Copie, MDPhD, Martin Hutchings, MD PhD, Annibale Versari, Michel Meignan, Massimo Federico, Marc Andre, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 736.
https://doi.org/10.1182/blood.V130.Suppl_1.736.736
Published: 2017
Journal Articles

Either Combined-Modality Or Radiotherapy Alone Provide Favorable Outcome In Stage I-II Mantle Cell Lymphoma: A Report Of 82 Patients From The International Lymphoma Radiation Oncology Group (ILROG)

Bouthaina S. Dabaja, MD, Richard Tsang, MD, Shunan Qi, Pamela Allen, PhD, David C. Hodgson, MD, Umberto Ricardi, MD, Richard T. Hoppe, MD, Andrea Ng, Lena Specht, Ye-xiong Li, MD, Stephanie Terezakis, MD, Louis Constine, MD, Joachim Yahalom, MD
Journal: Blood
Blood (2013) 122 (21): 4292.
https://doi.org/10.1182/blood.V122.21.4292.4292
Published: 2013
Journal Articles

Routine Bone Marrow Biopsy Adds Little Diagnostic Information in Patients with Newly Diagnosed Hodgkin Lymphoma Undergoing PET/CT Staging

Tarec Christoffer El-Galaly, Francesco d'Amore, MD, DMSci, Peter de Nully Brown, Ilse Christiansen, Lena Specht, Annika Loft, Anne Bukh, Hans E. Johnsen, Charlotte Madsen, Martin Hutchings
Journal: Blood
Blood (2011) 118 (21): 2627.
https://doi.org/10.1182/blood.V118.21.2627.2627
Published: 2011
Journal Articles

Final Results of a Phase II Danish Trial Testing Low Dose Total Body Irradiation Following Six Bi-Weekly RCHOP-14 Plus 2 Extra Rituximab in Elderly High risk Patients with Aggressive CD20+ Diffuse Large B-Cell Lymphoma (DLBCL).

Akmal Safwat, M.D., Lena Specht, M.D., Flemming Hansen, M.D., Mads Hansen, M.D., Jesper Jurlander, M.D., Francesco d’Amore, MD
Journal: Blood
Blood (2008) 112 (11): 1013.
https://doi.org/10.1182/blood.V112.11.1013.1013
Published: 2008
Journal Articles

Chemotherapy Alone Versus Chemotherapy Plus Radiotherapy for Early Stage Hodgkin Lymphoma.

Fareed A. Rehan, Corinne Brillant, Holger Schulz, Ina Knauel, Julia Bohlius, Lena Specht, Andreas Engert
Journal: Blood
Blood (2007) 110 (11): 2320.
https://doi.org/10.1182/blood.V110.11.2320.2320
Published: 2007
Journal Articles

Early Results of a Phase II Trial Testing Low Dose Total Body Irradiation (LTBI) after Chemoimmunotherapy in Elderly High Risk Patients with Diffuse Large B-Cell Lymphoma (DLBCL)

Akmal Safwat, MD, Lena Specht, M.D., Flemming Hansen, M.D., Mads Hansen, M.D., Jesper Jurlander, M.D., Anne Marie Boesen, M.D., Francesco d’Amore, M.D.
Journal: Blood
Blood (2007) 110 (11): 1296.
https://doi.org/10.1182/blood.V110.11.1296.1296
Published: 2007
Journal Articles

FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma

Clinical Trials & Observations
Martin Hutchings, Annika Loft, Mads Hansen, Lars Møller Pedersen, Thora Buhl, Jesper Jurlander, Simon Buus, Susanne Keiding, Francesco D'Amore, Anne-Marie Boesen, Anne Kiil Berthelsen, Lena Specht
Journal: Blood
Blood (2006) 107 (1): 52–59.
https://doi.org/10.1182/blood-2005-06-2252
Published: 2006
Journal Articles

Revised Response Criteria for Malignant Lymphomas From the Members of the International Harmonization Project (IHP) of the Competence Network Malignant Lymphoma, Represented by:.

Bruce D. Cheson, MD, Beate Pfistner, PhD, Malik E. Juweid, MD, Lena Specht, MD, PhD, Steven T. Rosen, MD, Randy Gascoyne, MD, Sigrid Stroobants, MD, PhD, Volker Diehl, MD
Journal: Blood
Blood (2005) 106 (11): 18.
https://doi.org/10.1182/blood.V106.11.18.18
Published: 2005
Journal Articles

Different Histopathological Subtypes of Hodgkin Lymphoma Have Significantly Different Levels of FDG Uptake.

Martin Hutchings, MD, Annika L. Jakobsen, PhD, Mads T. Hansen, DMSc, Elisabeth Ralfkiaer, DMSc, Lena Specht, DMSc
Journal: Blood
Blood (2005) 106 (11): 969.
https://doi.org/10.1182/blood.V106.11.969.969
Published: 2005